114 related articles for article (PubMed ID: 11758948)
1. Myocardial FDG-PET examination during fasting and glucose loading states by means of a one-day protocol.
Tsuchida T; Sadato N; Yonekura Y; Sugimoto K; Nakano A; Lee JD; Takahashi N; Waki A; Ishii Y; Itoh H
Ann Nucl Med; 2001 Oct; 15(5):433-8. PubMed ID: 11758948
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner.
van der Weerdt AP; Boellaard R; Visser FC; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1439-46. PubMed ID: 17333179
[TBL] [Abstract][Full Text] [Related]
3. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
[TBL] [Abstract][Full Text] [Related]
6. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
[TBL] [Abstract][Full Text] [Related]
7. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
[TBL] [Abstract][Full Text] [Related]
8. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
9. Experimental study on "ischemic memory" of myocardium with different ischemic degrees by
Li J; Zheng N; Zhang G; Bao B; Liu L; Hao L; Wang X
Ann Nucl Med; 2020 Jan; 34(1):24-30. PubMed ID: 31637598
[TBL] [Abstract][Full Text] [Related]
10. Delayed enhancement of myocardial FDG uptake on glucose loading FDG-PET in NIDDM patient.
Tsuchida T; Yonekura Y; Wada Y; Sadato N; Yamamoto K; Waki A; Nakano A; Lee JD; Hayashi N; Ishii Y
Ann Nucl Med; 1997 Nov; 11(4):331-4. PubMed ID: 9460526
[TBL] [Abstract][Full Text] [Related]
11. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
12. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
[TBL] [Abstract][Full Text] [Related]
13. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization.
Kaneta T; Hakamatsuka T; Takanami K; Yamada T; Takase K; Sato A; Higano S; Kinomura S; Fukuda H; Takahashi S; Yamada S
Ann Nucl Med; 2006 Apr; 20(3):203-8. PubMed ID: 16715951
[TBL] [Abstract][Full Text] [Related]
15. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
16. Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
van der Weerdt AP; Boellaard R; Knaapen P; Visser CA; Lammertsma AA; Visser FC
J Nucl Med; 2004 Feb; 45(2):169-75. PubMed ID: 14960632
[TBL] [Abstract][Full Text] [Related]
17. [PET assessment of myocardial viability with glucose loading and fasting FDG images].
Niwayama H; Yoshida K; Kagaya A; Himi T; Masuda Y; Inagaki Y; Ito Y; Uematsu S; Imazeki K; Arimizu N
Kaku Igaku; 1990 Mar; 27(3):285-8. PubMed ID: 2352373
[TBL] [Abstract][Full Text] [Related]
18. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose.
Ding HJ; Shiau YC; Wang JJ; Ho ST; Kao A
Nucl Med Commun; 2002 Oct; 23(10):961-5. PubMed ID: 12352594
[TBL] [Abstract][Full Text] [Related]
19. Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients.
Hasegawa S; Kusuoka H; Uehara T; Yamaguchi H; Hori M; Nishimura T
Ann Nucl Med; 1998 Dec; 12(6):363-8. PubMed ID: 9972374
[TBL] [Abstract][Full Text] [Related]
20. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Martin WH; Jones RC; Delbeke D; Sandler MP
Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
